Brown Advisory’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Brown Advisory's MRNA Position: Q2 2026 in Review
Brown Advisory increased its Moderna (MRNA) stake by 4.1% in Q2 2026, buying an estimated $28.2K and bringing the position to 13,889 shares worth $973K. The position accounts for ﹤0.01% of the portfolio, ranked #916.
Brown Advisory first reported a position in MRNA in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.02M in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Brown Advisory held 13,889 shares of Moderna worth $973K as of Q2 2026.
- Brown Advisory bought 545 Moderna shares in Q2 2026, an estimated $28.2K.
- Moderna made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #916 holding.
- Brown Advisory first reported a position in Moderna in Q1 2021 and has held it in 22 quarters since.
- Brown Advisory's Moderna position peaked at $1.02M in Q2 2024.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.